Data News > Nasdaq Compliance Update: PAVS, ACET, SRPT, BTOG, and ABEO Make Key Announcements
- PAVS regained compliance with Nasdaq minimum closing bid price rule
- ACET reported an inducement grant under Nasdaq listing rule 5635(c)(4)
- SRPT announced inducement grants under Nasdaq listing rule 5635(c)(4)
- BTOG regained compliance with Nasdaq listing rule 5250(c)(1)
- ABEO announced new employee inducement grants under Nasdaq listing rule 5635(c)(4)
Paranovus Entertainment Technology Limited, also known as PAVS, has officially regained compliance with the Nasdaq Listing Rule 5550(a)(2) as per a recent notification from the Nasdaq Stock Market LLC. The rule mandates that the company's Ordinary Shares must retain a minimum bid price of $1.00 per share, a threshold PAVS achieved by maintaining a closing bid price at or above $1.00 per share for 10 consecutive business days from December 13 to December 30, 2024.
Another noteworthy development comes from Adicet Bio, trading under the symbol ACET on Nasdaq. The clinical-stage biotechnology firm disclosed an inducement grant on December 31, 2024, under Nasdaq Listing Rule 5635(c)(4). This award was bestowed upon a new hire who was brought on board in December and received non-qualified stock options to procure 9,000 shares of Adicet's common stock at an exercise price of $0.96 per share.
Sarepta Therapeutics, identified on Nasdaq as SRPT, made headlines by announcing equity awards on December 31, 2024, in accordance with the company's 2024 Employment Commencement Incentive Plan. These awards, granted to 8 individuals hired in December 2024, were revealed as inducement grants approved by the Compensation Committee of Sarepta's Board of Directors under Nasdaq Listing Rule 5635(c)(4).
Bit Origin Ltd, operating as BTOG on Nasdaq, disclosed its successful regaining of compliance with Nasdaq Listing Rule 5250(c)(1) on December 31, 2024. This achievement was attributed to the filing of the company's annual report on Form 20-F for the fiscal year ended June 30, 2024. Bit Origin Ltd is recognized as an emerging growth firm specializing in the crypto mining sector with a focus on diversified expansion strategies.
Lastly, Abeona Therapeutics Inc., traded on Nasdaq as ABEO, shared news regarding equity awards granted to new non-executive employees who recently joined the company. These equity awards, greenlit in adherence to Nasdaq Listing Rule 5635(c)(4), were unveiled as part of Abeona Therapeutics' efforts to attract and retain top talent within the organization.
The Nasdaq-100, comprising the largest nonfinancial companies within the Nasdaq Composite, is wrapping up 2024 with a notable 28% gain, showcasing the remarkable performance of the tech-heavy index throughout the year. With PAVS, ACET, SRPT, BTOG, and ABEO all showcasing various compliance achievements and inducement grants, the Nasdaq landscape continues to be dynamic and ever-evolving in line with regulatory standards and market trends.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Nasdaq Compliance Update: PAVS, ACET, SRPT, BTOG, and ABEO Make Key Announcements
By KlickAnalytics Data Insights | December 31, 2024 08:03PM ET
Key Points
- PAVS regained compliance with Nasdaq minimum closing bid price rule
- ACET reported an inducement grant under Nasdaq listing rule 5635(c)(4)
- SRPT announced inducement grants under Nasdaq listing rule 5635(c)(4)
- BTOG regained compliance with Nasdaq listing rule 5250(c)(1)
- ABEO announced new employee inducement grants under Nasdaq listing rule 5635(c)(4)
Paranovus Entertainment Technology Limited, also known as PAVS, has officially regained compliance with the Nasdaq Listing Rule 5550(a)(2) as per a recent notification from the Nasdaq Stock Market LLC. The rule mandates that the company's Ordinary Shares must retain a minimum bid price of $1.00 per share, a threshold PAVS achieved by maintaining a closing bid price at or above $1.00 per share for 10 consecutive business days from December 13 to December 30, 2024.
Another noteworthy development comes from Adicet Bio, trading under the symbol ACET on Nasdaq. The clinical-stage biotechnology firm disclosed an inducement grant on December 31, 2024, under Nasdaq Listing Rule 5635(c)(4). This award was bestowed upon a new hire who was brought on board in December and received non-qualified stock options to procure 9,000 shares of Adicet's common stock at an exercise price of $0.96 per share.
Sarepta Therapeutics, identified on Nasdaq as SRPT, made headlines by announcing equity awards on December 31, 2024, in accordance with the company's 2024 Employment Commencement Incentive Plan. These awards, granted to 8 individuals hired in December 2024, were revealed as inducement grants approved by the Compensation Committee of Sarepta's Board of Directors under Nasdaq Listing Rule 5635(c)(4).
Bit Origin Ltd, operating as BTOG on Nasdaq, disclosed its successful regaining of compliance with Nasdaq Listing Rule 5250(c)(1) on December 31, 2024. This achievement was attributed to the filing of the company's annual report on Form 20-F for the fiscal year ended June 30, 2024. Bit Origin Ltd is recognized as an emerging growth firm specializing in the crypto mining sector with a focus on diversified expansion strategies.
Lastly, Abeona Therapeutics Inc., traded on Nasdaq as ABEO, shared news regarding equity awards granted to new non-executive employees who recently joined the company. These equity awards, greenlit in adherence to Nasdaq Listing Rule 5635(c)(4), were unveiled as part of Abeona Therapeutics' efforts to attract and retain top talent within the organization.
The Nasdaq-100, comprising the largest nonfinancial companies within the Nasdaq Composite, is wrapping up 2024 with a notable 28% gain, showcasing the remarkable performance of the tech-heavy index throughout the year. With PAVS, ACET, SRPT, BTOG, and ABEO all showcasing various compliance achievements and inducement grants, the Nasdaq landscape continues to be dynamic and ever-evolving in line with regulatory standards and market trends.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.